Physician profile
Brian Hendricks
NPI 1548527849
$3,978.66
in general payments reported to CMS, 2019-2025
12 companies · $2,035 in 2025
The $2,035 reported for 2025 was more than what 89% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $763 · 2020: $67.09 · 2021: $11.70 · 2022: $540 · 2023: $120 · 2024: $442 · 2025: $2,035.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,800 · Food and Beverage: $797.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,800.00 |
| Food and Beverage | $797.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verathon INC. | $1,800.00 | 2025 | Bronchoscope |
| Inspire Medical Systems, INC. | $787.61 | 2022-2025 | Inspire |
| Stryker Corporation | $518.78 | 2019-2025 | Audion Et Dilation System |
| Intersect Ent, INC. | $400.58 | 2019 | |
| Aerin Medical INC. | $186.28 | 2019-2020 | |
| Glaxosmithkline, LLC. | $103.69 | 2024 | Nucala |
| Regeneron Healthcare Solutions, INC. | $49.46 | 2019-2022 | |
| Optinose US, INC. | $38.52 | 2020-2022 | |
| Genzyme Corporation | $28.57 | 2022-2023 | |
| Acclarent, INC | $27.98 | 2022 | |
| Integra Lifesciences Corporation | $25.19 | 2019 | |
| Glenmark Therapeutics INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Hendricks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.